PAVMZ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 Jul 2024 @ 16:00):
Our systems believe the stock currently is overvalued by -0.49% compare to its pairs and should correct downwards.

Stats
Today's Volume	21 319
Average Volume	0
Market Cap	11.49M
EPS	$-1.750 ( Q1 \| 2024-05-13 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 43.86
ATR14	$0 (0.00%)

ABMD 0.00%

AMIX -1.04%

BBLGW -21.85%

BVS -0.35%

COCH 0.85%

DHAI 1.50%

DHAIW -2.00%

DNAY 8.33%

EYES -5.05%

GBS -1.58%

HSCS -2.88%

HSCSW -30.41%

IINNW 1.61%

INVO -3.16%

LFWD -5.74%

MDAI 10.80%

MGRM -6.05%

MXCT -2.30%

NVNOW -32.98%

NXL -1.78%

NXLIW -27.00%

OSA -7.35%

OSAAW -6.40%

PAVMW 105.67%

PAVMZ 49.50%

PETVW 0.00%

QTI 3.07%

QTNT 0.00%

Insider Trading

Date	Person	Action	Amount	type
2022-05-04	O'neil Shaun	Sell	25 935	Common stock
2022-02-22	O'neil Shaun	Sell	0	Common stock
2022-02-22	O'neil Shaun	Sell	195 108	Employee stock option (right to buy)
2022-02-22	O'neil Shaun	Sell	100 000	Employee stock option (right to buy)
2022-02-22	O'neil Shaun	Sell	75 000	Employee stock option (right to buy)

INSIDER POWER
100.00
Last 14 transactions
Buy: 2 950 000 \| Sell: 396 043

Correlation (AI algo v.1.1b): Overvalued: -0.49% $0.0300 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

PAVmed Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PAVmed Inc Financials

Annual	2023
Revenue:	$2.45M
Gross Profit:	$-6.90M (-281.40 %)
EPS:	$-8.87

FY	2023
Revenue:	$2.45M
Gross Profit:	$-6.90M (-281.40 %)
EPS:	$-8.87

FY	2022
Revenue:	$377 000
Gross Profit:	$-3.24M (-858.62 %)
EPS:	$-17.06

FY	2021
Revenue:	$500 000
Gross Profit:	$-85 000.00 (-17.00 %)
EPS:	$-1.150

Financial Reports:

No articles found.

PAVmed Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

PAVmed Inc

PAVmed Inc. operates as a medical device company in the United States. The company\'s lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett\'s Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.